Zoltán Doleschall

514 total citations
20 papers, 358 citations indexed

About

Zoltán Doleschall is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Zoltán Doleschall has authored 20 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Hematology. Recurrent topics in Zoltán Doleschall's work include Complement system in diseases (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Zoltán Doleschall is often cited by papers focused on Complement system in diseases (6 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Zoltán Doleschall collaborates with scholars based in Hungary, United Kingdom and Sweden. Zoltán Doleschall's co-authors include László Cervenak, Péter Gál, Veronika Makó, Márton Megyeri, Zoltán Prohászka, László Beinrohr, Péter Závodszky, Erika Kajdácsi, József Dobó and Péter K. Jani and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Zoltán Doleschall

19 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zoltán Doleschall Hungary 10 167 118 100 60 47 20 358
Guosu Wang United Kingdom 12 234 1.4× 180 1.5× 59 0.6× 40 0.7× 53 1.1× 13 506
J. Disse Germany 9 79 0.5× 179 1.5× 241 2.4× 80 1.3× 31 0.7× 10 477
Keiko Okada Japan 10 66 0.4× 118 1.0× 94 0.9× 48 0.8× 25 0.5× 41 400
Anahita Mojiri United States 12 53 0.3× 178 1.5× 80 0.8× 33 0.6× 33 0.7× 25 449
Jean-Marie Xuereb France 12 68 0.4× 279 2.4× 125 1.3× 38 0.6× 70 1.5× 17 506
Osamu Taniguchi Japan 11 178 1.1× 132 1.1× 81 0.8× 32 0.5× 20 0.4× 27 426
Makoto Osada Japan 13 114 0.7× 171 1.4× 155 1.6× 26 0.4× 42 0.9× 26 500
Dirk Völkel Austria 10 374 2.2× 131 1.1× 136 1.4× 54 0.9× 13 0.3× 13 538
G Klappacher Austria 5 343 2.1× 88 0.7× 29 0.3× 77 1.3× 32 0.7× 11 485
Floris van Alphen Netherlands 12 102 0.6× 83 0.7× 74 0.7× 45 0.8× 7 0.1× 15 315

Countries citing papers authored by Zoltán Doleschall

Since Specialization
Citations

This map shows the geographic impact of Zoltán Doleschall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoltán Doleschall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoltán Doleschall more than expected).

Fields of papers citing papers by Zoltán Doleschall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoltán Doleschall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoltán Doleschall. The network helps show where Zoltán Doleschall may publish in the future.

Co-authorship network of co-authors of Zoltán Doleschall

This figure shows the co-authorship network connecting the top 25 collaborators of Zoltán Doleschall. A scholar is included among the top collaborators of Zoltán Doleschall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoltán Doleschall. Zoltán Doleschall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doleschall, Zoltán, et al.. (2025). Human umbilical vein endothelial cell miRNA secretome highlights endothelial origin of serum miRNAs. Scientific Reports. 15(1). 24960–24960.
2.
Doleschall, Márton, Zoltán Herold, Zoltán Doleschall, et al.. (2022). Quantitative PCR from human genomic DNA: The determination of gene copy numbers for congenital adrenal hyperplasia and RCCX copy number variation. PLoS ONE. 17(12). e0277299–e0277299. 2 indexed citations
3.
Kajdácsi, Erika, Veronika Makó, András Masszi, et al.. (2019). MASP-1 Increases Endothelial Permeability. Frontiers in Immunology. 10. 991–991. 30 indexed citations
4.
Doleschall, Márton, Andrea Luczay, Kinga Hadzsiev, et al.. (2017). A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics. European Journal of Human Genetics. 25(6). 702–710. 13 indexed citations
5.
Jani, Péter K., Erika Kajdácsi, Zoltán Doleschall, et al.. (2017). Transcriptome analysis of inflammation-related gene expression in endothelial cells activated by complement MASP-1. Scientific Reports. 7(1). 10462–10462. 15 indexed citations
6.
Doleschall, Zoltán, et al.. (2016). Kinase-Associated Phosphoisoform Assay: a novel candidate-based method to detect specific kinase-substrate phosphorylation interactions in vivo. BMC Plant Biology. 16(1). 204–204. 8 indexed citations
7.
Jani, Péter K., Erika Kajdácsi, József Dobó, et al.. (2016). Complement MASP-1 enhances adhesion between endothelial cells and neutrophils by up-regulating E‐selectin expression. Molecular Immunology. 75. 38–47. 30 indexed citations
8.
Baczkó, István, László Hiripi, Katja E. Odening, et al.. (2016). A novel transgenic rabbit model with reduced repolarization reserve: long QT syndrome caused by a dominant‐negative mutation of the KCNE1 gene. British Journal of Pharmacology. 173(12). 2046–2061. 33 indexed citations
9.
Doleschall, Zoltán, et al.. (2015). [PI3K/AKT pathway activation and therapeutic consequences in breast cancer].. PubMed. 59(4). 346–51. 3 indexed citations
10.
Jani, Péter K., Erika Kajdácsi, Márton Megyeri, et al.. (2014). MASP-1 Induces a Unique Cytokine Pattern in Endothelial Cells: A Novel Link between Complement System and Neutrophil Granulocytes. PLoS ONE. 9(1). e87104–e87104. 43 indexed citations
11.
Cervenak, Judit, Márton Doleschall, Balázs Bender, et al.. (2013). NFκB induces overexpression of bovine FcRn. mAbs. 5(6). 860–871. 17 indexed citations
12.
Szabó, Julianna, Ágnes Szilágyi, Zoltán Doleschall, et al.. (2013). Both Positive and Negative Selection Pressures Contribute to the Polymorphism Pattern of the Duplicated Human CYP21A2 Gene. PLoS ONE. 8(11). e81977–e81977. 8 indexed citations
13.
Keltai, Katalin, et al.. (2010). Doxorubicin selectively suppresses mRNA expression and production of endothelin-1 in endothelial cells. Vascular Pharmacology. 53(5-6). 209–214. 12 indexed citations
14.
Megyeri, Márton, Veronika Makó, László Beinrohr, et al.. (2009). Complement Protease MASP-1 Activates Human Endothelial Cells: PAR4 Activation Is a Link between Complement and Endothelial Function. The Journal of Immunology. 183(5). 3409–3416. 106 indexed citations
15.
Megyeri, Márton, Veronika Makó, László Beinrohr, et al.. (2009). Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function. Molecular Immunology. 46(14). 2828–2829. 7 indexed citations
16.
Géczi, Lajos, Zoltán Doleschall, I. Bodrogi, et al.. (2004). Expression and prognostic value of the lung resistance-related protein (LRP) in germ cell testicular tumors.. PubMed. 24(2C). 1097–104. 6 indexed citations
17.
Géczi, Lajos, et al.. (2002). [Lung resistance protein analysis in testicular cancer].. PubMed. 46(4). 339–45. 1 indexed citations
18.
Péley, Gábor, et al.. (2000). [Prognostic factors of breast cancer]. PubMed. 44(1). 53–60. 1 indexed citations
19.
Péley, Gábor, et al.. (1999). Correlation of Biochemical Tumor Markers with Conventional Pathological Features in Primary Breast Cancer. The International Journal of Biological Markers. 14(1). 49–51. 3 indexed citations
20.
Csuka, Orsolya, et al.. (1997). Predictive value of p53, Bcl2 and bax in the radiotherapy of head and neck cancer. Pathology & Oncology Research. 3(3). 204–210. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026